Floatz logo

Inno-206

Philadelphia Chromosome Positive Adult Precursor Acute Lymphoblastic Leukemia

Mayo ClinicPhase 2Dormant
CCC
53/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
38/ 100
Competitive Position
95/ 100

Competitive context

0 Active assets in the Philadelphia Chromosome Positive Adult Precursor Acute Lymphoblastic Leukemia cohort.

Asset / SponsorPhaseRating
VINCRISTINE SULFATE
SWOG Cancer Research Network
Phase 2BB
Cyclophosphamide
SWOG Cancer Research Network
Phase 2BB
Cytosin-Arabinosid
Mayo Clinic
Phase 2BB
Calcium folinate pentahydrate
Mayo Clinic
Phase 2BB
METHOTREXATE
Mayo Clinic
Phase 2BB

View all 24 →

Same molecule, other indications

Inno-206 is also rated in:

adult acute lymphoblastic leukemiaDormant
BBB
Indicative ·
77 / 100
View asset →
plasma cell myelomaDormant
BBB
Indicative ·
77 / 100
View asset →
Recurrent Adult Acute Lymphoblastic LeukemiaDormant
BBB
Indicative ·
77 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →